Tissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma

Hong, 2012, Anticancer effects of KI-10F: a novel compound affecting apoptosis, angiogenesis and cell growth in colon cancer, Int J Oncol, 41, 1715, 10.3892/ijo.2012.1609

Amsterdam, 2012, Use of multiple biomarkers for the localization and characterization of colon cancer stem cells by indirect immunocytochemistry, Int J Oncol, 41, 285

Hu, 2010, Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice, BMC Cancer, 10, 235, 10.1186/1471-2407-10-235

Rak, 2009, Tissue factor in tumour progression, Best Pract Res Clin Haematol, 22, 71, 10.1016/j.beha.2008.12.008

Waxman, 1992, Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex, Biochemistry, 31, 3998, 10.1021/bi00131a015

Hu, 1999, Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model, Proc Natl Acad Sci USA, 96, 8161, 10.1073/pnas.96.14.8161

Tang, 2007, Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells, Cancer Gene Ther, 14, 346, 10.1038/sj.cgt.7701030

Hu, 2001, Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer, Proc Natl Acad Sci USA, 98, 12180, 10.1073/pnas.201420298

Hu, 2000, Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy, Proc Natl Acad Sci USA, 97, 9221, 10.1073/pnas.97.16.9221

Hu, 2011, Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer, Breast Cancer Res Treat, 126, 589, 10.1007/s10549-010-0957-1

Shoji, 2008, Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa, J Drug Target, 16, 185, 10.1080/10611860801890093

Nemerson, 1988, Tissue factor and hemostasis, Blood, 71, 1, 10.1182/blood.V71.1.1.1

Ruf, 1991, Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions, J Biol Chem, 266, 15719, 10.1016/S0021-9258(18)98469-3

Toomey, 1991, Localization of the human tissue factor recognition determinant of human factor VIIa, J Biol Chem, 266, 19198, 10.1016/S0021-9258(18)54982-6

Zhang, 2012, Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy, Int J Mol Med, 29, 409

Allen, 2002, Ligand-targeted therapeutics in anticancer therapy, Nat Rev Cancer, 2, 750, 10.1038/nrc903

He, 2002, Characteristics of mitotic cell death induced by enediyne antibiotic lidamycin in human epithelial tumor cells, Int J Oncol, 20, 261

Guo, 2010, A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity, Clin Cancer Res, 16, 2085, 10.1158/1078-0432.CCR-09-2699

Zhang, 2012, Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer, Cancer Biother Radiopharm, 27, 384, 10.1089/cbr.2012.1209

Drake, 1989, Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis, Am J Pathol, 134, 1087

Wilcox, 1989, Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque, Proc Natl Acad Sci USA, 86, 2839, 10.1073/pnas.86.8.2839

Hu, 2011, Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer, Breast Cancer Res Treat, 126, 589, 10.1007/s10549-010-0957-1

Senger, 1983, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid, Science, 219, 983, 10.1126/science.6823562

Xin, 2010, Efficient inhibition of B-cell lymphoma xenografts with a novel recombinant fusion protein: anti-CD20Fab-LDM, Gene Ther, 17, 1234, 10.1038/gt.2010.76